HDAC2 deficiency and histone acetylation

Nat Genet. 2008 Jul;40(7):812-3; author reply 813. doi: 10.1038/ng0708-812.
No abstract available

Publication types

  • Comment
  • Comparative Study
  • Letter

MeSH terms

  • Acetylation
  • Antineoplastic Agents / therapeutic use
  • Carcinoma / drug therapy
  • Carcinoma / enzymology
  • Carcinoma / genetics
  • Cell Line, Tumor
  • Colorectal Neoplasms / drug therapy
  • Colorectal Neoplasms / enzymology
  • Colorectal Neoplasms / genetics
  • Drug Resistance, Neoplasm / genetics
  • HCT116 Cells
  • HT29 Cells
  • Histone Deacetylase 2
  • Histone Deacetylase Inhibitors
  • Histone Deacetylases / genetics*
  • Histone Deacetylases / metabolism
  • Histones / metabolism*
  • Humans
  • Hydroxamic Acids / pharmacology
  • Hydroxamic Acids / therapeutic use
  • Repressor Proteins / antagonists & inhibitors
  • Repressor Proteins / genetics*
  • Repressor Proteins / metabolism

Substances

  • Antineoplastic Agents
  • Histone Deacetylase Inhibitors
  • Histones
  • Hydroxamic Acids
  • Repressor Proteins
  • trichostatin A
  • Histone Deacetylase 2
  • Histone Deacetylases